全文获取类型
收费全文 | 1436篇 |
免费 | 158篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 116篇 |
妇产科学 | 24篇 |
基础医学 | 131篇 |
口腔科学 | 41篇 |
临床医学 | 211篇 |
内科学 | 341篇 |
皮肤病学 | 18篇 |
神经病学 | 55篇 |
特种医学 | 216篇 |
外科学 | 121篇 |
综合类 | 43篇 |
预防医学 | 54篇 |
眼科学 | 21篇 |
药学 | 84篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 128篇 |
出版年
2022年 | 4篇 |
2021年 | 12篇 |
2020年 | 19篇 |
2019年 | 25篇 |
2018年 | 35篇 |
2017年 | 33篇 |
2016年 | 32篇 |
2015年 | 44篇 |
2014年 | 31篇 |
2013年 | 35篇 |
2012年 | 39篇 |
2011年 | 48篇 |
2010年 | 57篇 |
2009年 | 58篇 |
2008年 | 45篇 |
2007年 | 33篇 |
2006年 | 28篇 |
2005年 | 35篇 |
2004年 | 25篇 |
2003年 | 27篇 |
2002年 | 34篇 |
2001年 | 20篇 |
2000年 | 23篇 |
1999年 | 30篇 |
1998年 | 87篇 |
1997年 | 87篇 |
1996年 | 93篇 |
1995年 | 62篇 |
1994年 | 58篇 |
1993年 | 47篇 |
1992年 | 23篇 |
1991年 | 26篇 |
1990年 | 16篇 |
1989年 | 45篇 |
1988年 | 31篇 |
1987年 | 43篇 |
1986年 | 21篇 |
1985年 | 33篇 |
1984年 | 25篇 |
1983年 | 20篇 |
1982年 | 17篇 |
1981年 | 22篇 |
1980年 | 12篇 |
1979年 | 10篇 |
1978年 | 8篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1975年 | 9篇 |
1974年 | 3篇 |
1973年 | 4篇 |
排序方式: 共有1609条查询结果,搜索用时 15 毫秒
1.
PJ Commerford 《Cardiovascular journal of Africa》2015,26(4):151-Aug;26(4):151
2.
Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. 总被引:6,自引:1,他引:5
下载免费PDF全文
![点击此处可从《The Journal of clinical investigation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
H Chiao S Foster R Thomas J Lipton R A Star 《The Journal of clinical investigation》1996,97(9):2038-2044
Alpha-Melanocyte-stimulating hormone (MSH) is a potent anti-inflammatory agent in many models of inflammation, suggesting that it inhibits a critical step common to different forms of inflammation. We showed previously that alpha-MSH inhibits nitric oxide (NO) production in cultured macro-phages. To determine how alpha-MSH acts in vivo, we induced acute hepatic inflammation by administering endotoxin (LPS) to mice pretreated with Corynebacterium parvum, alpha-MSH prevented liver inflammation even when given 30 min after LPS administration. To determine the mechanisms of action of alpha-MSH, we tested its influence on NO, infiltrating inflammatory cells, cytokines, and chemokines. Alpha-MSH inhibited systemic NO production, hepatic neutrophil infiltration, and increased hepatic mRNA abundance for TNF alpha, and the neutrophil and monocyte chemokines (KC/IL-8 and MCP-1). We conclude that alpha-MSH prevents LPS-induced hepatic inflammation by inhibiting production of chemoattractant chemokines which then modulate infiltration of inflammatory cells. Thus, alpha-MSH has an effect very early in the inflammatory cascade. 相似文献
3.
Hans Bosma Martin PJ van Boxtel Gertrudis IJM Kempen Jacques ThM van Eijk Jelle Jolles 《BMC public health》2007,7(1):179
Background
The aims of this study were to examine the extent to which higher intellectual abilities protect higher socio-economic groups from functional decline and to examine whether the contribution of intellectual abilities is independent of childhood deprivation and low birth weight and other socio-economic and developmental factors in early life. 相似文献4.
5.
Duvic Madeleine Chiao Nor Talpur Rakhshandra 《Journal of cutaneous medicine and surgery》2003,7(2):3-7
Journal of Cutaneous Medicine and Surgery - 相似文献
6.
7.
Previous reports in the literature have described correlation of increasing repeat length with severity of the phenotype, in Kennedy syndrome. We describe male siblings with different repeat lengths, with lack of expression of the phenotype in the sibling with the longer repeat length. The phenotype was identical to motor neurone disease. There is variability of expression in Kennedy syndrome and repeat length even in siblings cannot be taken as a conclusive indicator of severity. CAG repeat length cannot be used to predict the natural history of Kennedy disease. The diagnosis of Kennedy syndrome should be considered in male patients presenting with atypical motor neurone disease. 相似文献
8.
PJ Woll PhD MRCP R Pettengell PhD FRACP 《International journal of clinical practice》1997,51(2):111-115
SUMMARY The interferons are natural glycoproteins secreted in response to various stimuli, including viral infection. They have antiviral, antiproliferative and immunomodulatory effects on different target cell populations. Since recombinant human interferons have become available, they have been tested in a wide range of malignancies. They are well established in the treatment of hairy cell leukaemia, chronic myelogenous leukaemia and multiple myeloma. Although they have documented activity against lymphoma, melanoma, renal cell cancer and carcinoid tumours, their role in the treatment of these tumours is less clear. In the common solid tumours, such as lung cancer and colorectal cancer, the use of interferons remains experimental. Here we will summarise their practice applications in oncology, using randomised studies where available to establish their place in multi-modality treatment. We will not discuss their use as antiviral or immunomodulating agents in viral and autoimmune diseases, multiple sclerosis or after organ transplantation. 相似文献
9.
10.